Resynchronization: Considering device-based cardiac therapy in older adults

Journal of the American Geriatrics Society

Volumn 61, Issue 4, 2013, Pages 615-621

  Kramer, Daniel B ^a,b,c   Reynolds, Matthew R ^b,c   Mitchell, Susan L ^a,b,c  

^a Hebrew Seniorlife's Res Institute   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cardiac resynchronization therapy; heart failure; implantable cardioverter defibrillators; pacemakers

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART STROKE VOLUME; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MITRAL VALVE REGURGITATION; PACEMAKER; QRS COMPLEX;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; COMPARATIVE EFFECTIVENESS RESEARCH; DISEASE MANAGEMENT; FEMALE; HEALTH SERVICES FOR THE AGED; HEART FAILURE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84876297694     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12174     Document Type: Article

References (39)

1. Epstein AE, Kay GN, Plumb VJ, et al. Implantable cardioverter- defibrillator prescription in the elderly. Heart Rhythm 2009; 6: 1136-1143.
2. Hammill SC, Kremers MS, Stevenson LW, et al. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm 2010; 7: 1340-1345.
3. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
4. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008; 52: 1834-1843.
5. Yu CM, Chan JY, Zhang Q, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009; 361: 2123-2134.
6. Medtronic, Inc. Medtronic receives FDA approval to treat mildly symptomatic heart failure patients through expanded indication for CRT-D [on-line]. Available at http://wwwp.medtronic.com/Newsroom/NewsReleaseDetails. do?itemId=1334060694116&lang=en-US Accessed October 15, 2012.
7. Feldman AM, de Lissovoy G, Bristow MR, et al. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. J Am Coll Cardiol 2005; 46: 2311-2321.
8. Yao G, Freemantle N, Calvert MJ, et al. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007; 28: 42-51.
9. Fox M, Mealing S, Anderson R, et al. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: Systematic review and economic model. Health Technol Assess 2007; 11: iii-iv, ix-248.
10. Forman DE, Rich MW, Alexander KP, et al. Cardiac care for older adults. Time for a new paradigm. J Am Coll Cardiol 2011; 57: 1801-1810.
11. Jarcho JA,. Biventricular pacing. N Engl J Med 2006; 355: 288-294.
12. Bilchick KC, Helm RH, Kass DA,. Physiology of biventricular pacing. Curr Cardiol Rep 2007; 9: 358-365.
13. Solis J, McCarty D, Levine RA, et al. Mechanism of decrease in mitral regurgitation after cardiac resynchronization therapy: Optimization of the force-balance relationship. Circ Cardiovasc Imaging 2009; 2: 444-450.
14. Gold MR, Birgersdotter-Green U, Singh JP, et al. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J 2011; 32: 2516-2524.
15. Verhaert D, Popovic ZB, De S, et al. Impact of mitral regurgitation on reverse remodeling and outcome in patients undergoing cardiac resynchronization therapy. Circ Cardiovasc Imaging 2012; 5: 21-26.
16. Sitges M, Vidal B, Delgado V, et al. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation. Am J Cardiol 2009; 104: 383-388.
17. Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2012; 126: 1784-1800.
18. Stevenson WG, Hernandez AF, Carson PE, et al. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. J Card Fail 2012; 18: 94-106.
19. Reynolds CR, Jessup M,. Translating the benefits of cardiac resynchronization therapy widely and wisely: Challenges remain. Ann Intern Med 2011; 154: 436-438.
20. Jessup M,. MADIT-CRT-breathtaking or time to catch our breath? N Engl J Med 2009; 361: 1394-1396.
21. Kramer DB, Josephson ME,. Three questions for evidence-based cardiac electrophysiology. Circ Cardiovasc Qual Outcomes 2010; 3: 704-709.
22. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
23. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
24. Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010; 363: 2385-2395.
25. Daubert C, Gold MR, Abraham WT, et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: Insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol 2009; 54: 1837-1846.
26. Penn J, Goldenberg I, Moss AJ, et al. Improved outcome with preventive cardiac resynchronization therapy in the elderly: A MADIT-CRT substudy. J Cardiovasc Electrophysiol 2011; 22: 892-897.
27. Wells G, Parkash R, Healey JS, et al. Cardiac resynchronization therapy: A meta-analysis of randomized controlled trials. Can Med Assoc J 2011; 183: 421-429.
28. Bertoldi EG, Polanczyk CA, Cunha V, et al. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: An updated meta-analysis. Does recent evidence change the standard of care? J Card Fail 2011; 17: 860-866.
29. Delnoy PP, Ottervanger JP, Luttikhuis HO, et al. Clinical response of cardiac resynchronization therapy in the elderly. Am Heart J 2008; 155: 746-751.
30. Bleeker GB, Schalij MJ, Molhoek SG, et al. Comparison of effectiveness of cardiac resynchronization therapy in patients <70 versus > or =70 years of age. Am J Cardiol 2005; 96: 420-422.
31. Tsai V, Goldstein MK, Hsia HH, et al. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes 2011; 4: 549-556.
32. Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: A scientific statement from the American Heart Association. Circulation 2012; 125: 1928-1952.
33. Kramer DB, Ottenberg AL, Gerhardson S, et al. "Just because we can doesn't mean we should": Views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators. J Interv Card Electrophysiol 2011; 32: 243-252.
34. Goldstein NE, Lampert R, Bradley E, et al. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004; 141: 835-838.
35. Kaufman SR, Mueller PS, Ottenberg AL, et al. Ironic technology: Old age and the implantable cardioverter defibrillator in US health care. Soc Sci Med 2011; 72: 6-14.
36. Lampert R, Hayes DL, Annas GJ, et al. HRS Expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010; 7: 1008-1026.
37. Goldstein N, Carlson M, Livote E, et al. Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey. Ann Intern Med 2010; 152: 296-299.
38. Teno JM, Landrum K, Lynn J,. Defining and measuring outcomes in end-stage dementia. Alzheimer Dis Assoc Disord 1997; 11 (Suppl 6): 25-29.
39. Kramer DB, Buxton AE, Zimetbaum PJ,. Time for a change-a new approach to ICD replacement. N Engl J Med 2012; 366: 291-293.